Skip to main content
. 2019 Nov 6;14:194. doi: 10.1186/s13014-019-1395-9

Table 1.

Patient characteristics and further treatment of local or distant tumour relapse

standard group (IMRT only) experimental group (IMRT + C12)
number of patients 37 58
deceased 30 (81%) 26 (45%)
mean OS (months) 68.4 78.3
local relapse 23 (62%) 29 (50%)
 surgery 4 (17%) 17 (59%)
 re-RT 14 (61%) 13 (45%)
 re-RT as C12 1 (8%) 8 (62%)
 chemotherapy 1 (4%)
distant metastases 16 (43%) 22 (38%)
 chemotherapy 16 (100%) 21 (95%)
 palliative RT 5 (31%) 8 (36%)